A baby in Pennsylvania has become the first recipient of an experimental genetic therapy that targets a rare urea cycle disorder. The treatment, which involves customizing the gene editing process specifically for an individual’s “faulty” genes, could prove life-saving for the handful of infants born with the condition each year.The …
Read More »
#Bizwhiznetwork.com Innovation ΛI |Technology News